Resonant Capital Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.89M | Buy |
15,546
+1,009
| +7% | +$187K | 0.18% | 93 |
|
|
2025
Q1 | $3.05M | Buy |
14,537
+150
| +1% | +$31.4K | 0.21% | 84 |
|
|
2024
Q4 | $2.56M | Sell |
14,387
-121
| -0.8% | -$21.5K | 0.19% | 96 |
|
|
2024
Q3 | $2.87M | Buy |
14,508
+931
| +7% | +$184K | 0.21% | 89 |
|
|
2024
Q2 | $2.33M | Buy |
13,577
+327
| +2% | +$56.1K | 0.19% | 94 |
|
|
2024
Q1 | $2.41M | Buy |
13,250
+823
| +7% | +$150K | 0.21% | 94 |
|
|
2023
Q4 | $1.93M | Buy |
12,427
+51
| +0.4% | +$7.9K | 0.19% | 106 |
|
|
2023
Q3 | $1.84M | Buy |
12,376
+4
| +0% | +$596 | 0.2% | 95 |
|
|
2023
Q2 | $1.67M | Sell |
12,372
-300
| -2% | -$40.4K | 0.18% | 104 |
|
|
2023
Q1 | $2.02M | Sell |
12,672
-60
| -0.5% | -$9.56K | 0.23% | 94 |
|
|
2022
Q4 | $2.06M | Buy |
12,732
+749
| +6% | +$121K | 0.26% | 92 |
|
|
2022
Q3 | $1.61M | Buy |
11,983
+348
| +3% | +$46.7K | 0.24% | 89 |
|
|
2022
Q2 | $1.78M | Buy |
11,635
+429
| +4% | +$65.7K | 0.28% | 87 |
|
|
2022
Q1 | $1.82M | Buy |
11,206
+350
| +3% | +$56.9K | 0.27% | 78 |
|
|
2021
Q4 | $1.47M | Buy |
10,856
+780
| +8% | +$106K | 0.22% | 85 |
|
|
2021
Q3 | $1.09M | Buy |
10,076
+842
| +9% | +$90.8K | 0.19% | 89 |
|
|
2021
Q2 | $1.04M | Buy |
9,234
+13
| +0.1% | +$1.46K | 0.2% | 86 |
|
|
2021
Q1 | $998K | Buy |
9,221
+1,310
| +17% | +$142K | 0.21% | 84 |
|
|
2020
Q4 | $848K | Sell |
7,911
-312
| -4% | -$33.4K | 0.2% | 86 |
|
|
2020
Q3 | $720K | Sell |
8,223
-653
| -7% | -$57.2K | 0.21% | 84 |
|
|
2020
Q2 | $871K | Buy |
8,876
+104
| +1% | +$10.2K | 0.25% | 83 |
|
|
2020
Q1 | $668K | Buy |
8,772
+341
| +4% | +$26K | 0.24% | 108 |
|
|
2019
Q4 | $746K | Buy |
+8,431
| New | +$746K | 0.24% | 117 |
|